Communications

Articles scientifiques publiés

2018

  • Troughton R, Birgand G, Johnson AP, Naylor N, Gharbi M, Aylin P, Hopkins S, Jaffer U, Holmes A. Mapping national surveillance of surgical site infections (SSIs) to national needs and priorities: an assessment of England’s surveillance landscape. J Hosp Infect. 2018 Jun 12. PMID: 29906490
  • Lemaignen A, Armand-Lefevre L, Birgand G, Mabileau G, Lolom I, Ghodbane W, Dilly Marie P, Nataf P, Lucet JC. Thirteen-year Experience with Universal Staphylococcus aureus Nasal Decolonisation Prior to Cardiac Surgery: a quasi-experimental study. J Hosp Infect. 2018 May 4. PMID: 29733924
  • Bourigault C, Le Gallou F, Bodet N, Musquer N, Juvin ME, Corvec S, Ferronnière N, Wiesel S, Gournay J, Birgand G, Le Rhun M, Lepelletier D. Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway. J Hosp Infect. 2018 Aug;99(4):422-426. PMID: 29684421
  • Fournier S, Desenfant L, Monteil C, Nion-Huang M, Richard C, Jarlier V; The Ap-Hp Outbreaks Control Group. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015. Euro Surveill. 2018 Feb;23(8). PMID: 29486831
  • Birgand G; Castro-Sánchez E; Hansen S; Gastmeier P; Lucet JC; Ferlie E; Holmes A; Ahmad R. Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries. Accepted for publication in Antimicrobial Resistance & Infection Control
  • Perozziello A, Routelous C, Charani E, Truel A, Birgand G, Yazdanpanah Y, Lescure FX, Lucet JC; CEFECA study group. The experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study. Int J Antimicrob Agents. 2018 Jan 12.

2017

  • Birgand G, Zahar JR, Lucet JC. Insight into the complex epidemiology of multidrug-resistant Enterobacteriaceae. Clin Infect Dis. 2017 Sep 15. PMID: 29020395
  • Kardas L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppe E, Boelle PY, Andremont A, Yazdanpanah Y. Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase–producing Enterobacteriaceae in intensive care units? A cost-effectiveness analysis. BMJ Open. 2017 Nov 3;7(11):e017402.
  • Birgand G, Hayatgheib N, Bémer P, Guilloteau V, Legeay C, Perron S, Chapelet G, Corvec S, Bourigault C, Batard E, Lepelletier D; MiHAR study group.

    J Hosp Infect. 2017 Aug 1. PMID: 28774743

  • Birgand G, Troughton R, Moore L, Castro-Sánchez E, Charani E, Rawson T, Holmes A. Blogging in infectious diseases and clinical microbiology: Assessment of the ‘blogosphere’ content. Infect Control Hosp Epidemiol. 2017 Jul;38(7):832-839. doi: 10.1017/ice.2017.69. Epub 2017 May 18. PMID: 28516820
  •  Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G. Dress code and traffic flow in the operating room: A multicentre study of staff discipline during surgical procedures. Accepted for publication in Journal of Hospital Infection
  • Iwami M, Ahmad R, Castro-Sánchez E, Birgand G, Holmes A. Can English hospitals measure up? Qualitative analysis of English hospitals’ capacity to use European recommended indicators for successful infection prevention and control. BMJ Open. 2017 Jan 23;7(1):e012520.
  • Guilley-Lerondeau B, Bourigault C, Guille des Buttes AC, Birgand G, Lepelletier D. Adverse effects of isolation: a prospective matched cohort study including 90 direct interviews of hospitalized patients in a French University Hospital. Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):75-80.

2016

  • Vella V, Aylin PP, Moore L, King A, Naylor NR, Birgand GJ, Lishman H, Holmes A. Bed utilisation and increased risk of Clostridium difficile infections in acute hospitals in England in 2013/2014. BMJ Qual Saf. 2016 Sep 6. PMID: 27601687
  • Vella V, Moore L, Robotham J, Davies F, Birgand G, Otter J, Branigam, Diakova E, Knight G, Mookerjee S, Holmes A. Isolation demand from CPE screening strategies based on  a West London hospital network. Accepted for publication Journal of Hospital Infection
  • Birgand G, Lucet JC. Comportements des soignants vis-à-vis du risque infectieux : quelles influences et comment impulser le changement ? HYGIÈNES – 2016 – Volume XXIV – n° 1
  • Birgand G, Leroy C, Nerome S, Luong Nguyen L, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, MarcadeG, Fihman V, Nicolas-Chanoine MH, Pelat C,, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD,  Lucet JC. Costs associated with implementation of a strict national policy for controlling   spread of highly resistant microorganisms. BMJ Open. 2016 Jan 29;6(1):e009029. PMID:26826145
  • Pelat C, Kordas L, Birgand G, Ruppé E, Andremont A, Lucet JC, Yazdanpanah Y. Hand Hygiene, Cohorting or Antibiotic Restriction to Control Outbreaks of Multi-drug resistant Enterobacteriaceae. Infect Control Hosp Epidemiol. 2016 Mar;37(3):272-80. PMID:26708383
  • Birgand G, Moore L, Bourigault C, Vella V, Lepelletier D, Holmes A, Lucet JC. Measures to eradicate multidrug-resistant organism outbreaks: How much does it cost? Clin Microbiol Infect. 2016 Feb;22(2):162.e1-9. PMID:26482264

2015

  • Birgand G, Johansson A, Szilagyi E, Lucet JC. Overcoming the obstacles of implementing infection prevention and control guidelines. Clin Microbiol Infect. 2015 Dec;21(12):1067-71. PMID:26369604
  • Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC. Sternal wound infection after Cardiac Surgery: Incidence and Risk Factors According to Clinical Presentation. Clin Microbiol Infect. 2015 Jul;21(7):674.e11-8. PMID:25882356
  • Birgand G,Toupet G, Rukly S, Antoniotti G, Deschamps MN, Lepelletier D, Pornet C, Stern JB,Vandamme YM, Van der Mée – Maquet N, Timsit JF, Lucet JC. Air contamination for predicting wound contamination in clean surgery: a large multicenter study. Am J Infect Control. 2015 May 1;43(5):516-21. PMID:25752955
  • Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L’Heriteau F, Armand-Lefevre L, Lucet JC. Staphylococcus aureus healthcare-associated bacteremia: an indicator of catheter related infections. Med Mal Infect. 2015 Mar;45(3):84-8. PMID:25676476
  • Birgand G, Saliou P, Lucet JC. Influence of Staff Behavior on Infectious Risk in Operating Rooms: what is the Evidence?. Infect Control Hosp Epidemiol. 2015 Jan;36(1):93-106. PMID:25627767
  • Birgand. G. Le risque infectieux au bloc : approche comportementale. Interbloc 2015

2014

  • Le Dorze M., Gault N., Foucrier A., Ruppé E., Mourvillier B., Woerther P.L., Birgand G., Montravers P., Dilly M.P., Tubach F., Andremont A., Timsit J.F., Wolff M., Armand-Lefèvre L. Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia. Clin Microbiol Infect. 2014 Dec 26.
  • Birgand G, Schwarzinger M, Perozziello A, Pelat C, Ruppé E, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC. Prolonged Hospital Stay, an Adverse Effect of Strict National Policy for Controlling the Spread of Highly Resistant Microorganisms. Infect Control Hosp Epidemiol. 2014 Nov;35(11):1427-9
  • Fournier S, Monteil C, Lepainteur M, Richard C, Brun-Buisson C, Jarlier V, AP-HP Outbreaks Control Group. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012. Eurosurveillance published on 15 May 2014
  • Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC. Introduction of highly-resistant bacteria into a hospital via patients repatriated or recently hospitalised in a foreign country. Clin Microbiol Infect. 2014 Nov;20(11):O887-90.
  • Neulier C, Birgand G, Ruppe E, Armand-Lefevre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A. Bacteraemia due to Enterobacteriacae: when do we need to suspect an ESBLPE? Médecine Maladies Infectieuses January 2014

2013

  • Birgand G, Azevedo C, Toupet G, Pissard R, Grandbastien B, Fleury E, Lucet J-C. Attitude and infectious risk in the operating room – The ARIBO study protocol. BMJ open December 2013
  • Birgand G, Ruimy R, Schwarzinger M,  Lolom I, Bendgelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC.Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrobial Resistant and Infection Control, nov 2013. Article ARIC genXpert final
  • Birgand G, Lepelletier D, Baron G, Barrett S, Breier A-C, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J,  Lyytikainen O,   Sheridan E, Szilagyi E, Tacconelli E, Troillet N,  Ravaud P, Lucet JC and the VARSSI study group; Agreement among European health care professionals in diagnosing case vignette-based surgical site infections. Plos one 9 juillet 2013 Agreement Pone july 2013
  • Defrance G, Birgand G, Ruppé E, Billard M, Ruimy R, Bonnal C, Andremont A, Armand-Lefevre L. Time to positivity based discrimination between Enterobacteriacae, Pseudomonas aeruginosa and strictly anaerobic Gram negative bacilli in aerobic and anaerobic blood culture vials. Journal of Microbiol Methods 2013 Feb 27 TTP hemocs 2013
  • Birgand G, Lucet JC; Politique de dépistage des BMR: quand et qui faut-il dépister? Hygiènes, Novembre 2014, n° 4, Volume XXII; Revue Francophone des Laboratoires Juin 2013 Dépistage des BMR RFL mai 2013

2012

  • Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly M-P, Nataf P, Lucet J-C.  Does a Gentamicin-Impregnated Collagen Sponge Reduce Sternal Wound Infections in High-Risk Cardiac Surgery Patients?.  Interactive Cardiovascular and Thoracic Surgery. 2012 Oct 31 Collatamp ICVTS
  • Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of Colonization by Extended Spectrum β-Lactamase producing Enterobacteriaceae after Hospital Discharge. Am J Infect Control. 2012 Sep 18 Durée portage BLSE AJIC 2013

2011

  • Lucet JC, Birgand G. Les bacilles à Gram négatif multi-résistants : où va-t-on ? Journal des Anti-infectieux Vol 13 – N°2 – Juin 2011 BGN MR Lucet Birgand JAI juin 2011

2010

  • Decré D, Birgand G, Geneste D, Maury E, Petit JC, Barbut F, Arlet G. Possible imporation and subsequent cross- transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Eurosurveillance Novembre 2010 Euro OXA 48 2010
  • Birgand G, Blanckaert K, Coignard B, Carbonne A, Barbut F, Eckert C, Grandbastien B, Kadi Z, Desenclos JC, Astagneau P. Investigation of a large outbreak of Clostridium difficile 027 ribotype -associated disease in northern France” Eurosurveillance Mai 2010 C.diff 027 Eurosurv 2010
  • Birgand G, Miliani K, Carbonne A, Astagneau P. Is a High use of antibiotics linked with Clostridium difficile PCR- ribotype 027 infections in North of France? “ Infection Control and Hospital Epidemiology. 2010 Mar;31(3):302-5. ICD ATB ICHE 2010

2009

  • Birgand G, « Enterococci Resistant to Glycopeptides: What’s the Problem » Current Anaesthesia & Critical Care, Volume 20, Issues 5-6, October-December 2009, Pages 248-250 CACC GRE 2009

Chapitres de livres:

  • Lucet JC, Birgand G, A Pourbaix, M Dubert. Médiastinite après chirurgie cardiaque. Anesthésie – Réanimation en Chirurgie Cardiaque. 2eme edition

Communications orales en congrès:

  • Birgand G, Azevedo C, Pissard-Gibollet R, Toupet G, Rukly S, Antoniotti G, Deschamps M.N.,. Lepelletier D, Pornet C., Stern J.B., Vandamme Y.M., Van der Mée – Maquet N., Timsit J.F., Lucet  J.C. Doors opening and infectious risk in clean surgery: A Prospective, Cross-sectional Study. ECCMID 2016, Amsterdam
  • Birgand G, Précautions complémentaires contact à l’heure de la pandémie d’EBLSE : Intransigeance ou souplesse ? Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2015. 
  • Birgand G, Diagnostics rapides et fiables : Impact sur les mesures d’hygiène et les coûts. Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2015. 
  • Birgand G, Best-of de la littérature. Pneumopathies et Cathéters veineux. Congrès de la Société Française d’Hygiène Hospitalière 2015
  • Birgand G, La stratégie de maîtrise des BHRe est-elle coût-efficace ? Congrès de la Société Française d’Hygiène Hospitalière 2015
  • Birgand G, Leroy C, Nerome S, Luong Nguyen L, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, MarcadeG, Fihman V, Nicolas-Chanoine MH, Pelat C,, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD,  LucetJC. Costs associated with implementation of a strict national policy for controlling   spread of highly resistant microorganisms. Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2014.  & ECCMID 2015 Copenhague
  • Birgand G, La strategie de maitrise des BRHe est elle cout efficace? Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2014 
  • Lepainteur M, Birgand G, Armand-Lefevre L, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC. Introduction of highly-resistant bacteria into a hospital via patients repatriated or recently hospitalised in a foreign country. Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2013 Rapat RICAI 15nov2013 ML JCL
  • Reibel F, Ruppé E, Birgand G, Lolom I, Armand-Lefèvre L, Andremont A, Lucet JC. Are Glycopeptide resistant enterococci spreading easier than Carbapenemase producing enterobacteriacae ? Assessment of 3 co-colonised patients. Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris December 2013 ricai 14 11 coporteurs
  • Pelat C, Birgand G, Ruppé E, Schwarzinger M,  Andremont A,  Lucet JC,  Yazdanpanah Y. Hand Hygiene, Cohort Nursing or Antibiotic Restriction to Control Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL-PE) Transmission: Back to Basics. ICAAC, Denver USA September 2013
  • Birgand G,  Lolom I,  Ruppe E, Armand-Lefevre L, Belorgey S,  Andremont A, Lucet J-C. Are strict search-and-isolate strategies negotiable for controlling the spread of highly resistant bacteria?International Conference on Prevention & Inefction Control ICPIC, Geneva June 2013 ICPIC 2013 BHR final
  • Birgand G, Schwarzinger M, Perozziello A, Pelat C, Ruppé E, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC. Economic and medical adverse effects of a national policy to control the spread of highly resistant micro-organisms. Prix médical de la SF2H 2013, Paris BHR medicoeco ECCMID2013 25avr
  • Birgand G,Lepelletier D, Baron G, Barrett S, Breier A-C, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J,  yytikainen O,   Sheridan E, Szilagyi E, Tacconelli E, Troillet N,  Ravaud P, Lucet JC and the VARSSI study group; Agreement among healthcare professionals in diagnosing case vignette-based surgical site infections in 10 European countries. ECCMID 2013, Berlin Prés VARISO2 ECCMID 25avril
  • Birgand G, Schwarzinger M, Perozziello A, Pelat C, Ruppé E, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC. Economic and medical adverse effects of a national policy to control the spread of highly resistant micro-organisms. ECCMID 2013, Berlin
  • Birgand G, Ruimy R, Schwarzinger M, Lolom I, Belorgey S,  Houhou N,  Armand-Lefevre L, Yazdanpanah Y,  Andremont A,  Lucet J-C. PCR en temps réel dans une stratégie de maitrise des Entérocoques résistant aux Glycopeptides (ERG) : des économies ou un surcoût ? Présentation à la Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris Décembre 2012 Ricai 2012 GeneXpert 20nov
  • Lolom I, Armand-Lefevre L,  Birgand G,  Ruppe E, Andremont A,  Lucet J-C. Prévalence du portage d’entérobactéries BLSE autour de porteurs d’entérobactéries productrices de carbapénémases (EPC). Présentation à la Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris Décembre 2012 Preval BLSE RICAI 2012 Version Def231112
  • Lolom I, El Assali A,  Birgand G, Belorgey S, Andremont A,  LucetJ-C. Système informatisé d’alerte pour la gestion des patients contacts de porteurs de bactéries hautement résistantes (BHR). Présentation à la Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris Décembre 2012 
  • Birgand G,  Lolom I,  Ruppe E, Armand-Lefevre L, Belorgey S,  Andremont A, Lucet J-C. La maîtrise de la diffusion des bactéries hautement résistantes (BHR) passe-t-elle par l’application systématique des recommandations ? Présentation à la Réunion interdisciplinaire de chimiothérapie anti-infectieuse, Paris Décembre 2012 Ricai 2012 BHR 20nov
  • Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of Colonization by Extended Spectrum β-Lactamase
Plugin developed by Jon Fox